Background: Cells release extracellular vesicles (ECVs) that can influence differentiation, modulate the immune response, promote coagulation, and induce metastasis. Many ECVs form by budding outwards from the plasma membrane, but the molecules that regulate budding are unknown. In ECVs, the outer leaflet of the membrane bilayer contains aminophospholipids that are normally sequestered to the inner leaflet of the plasma membrane, suggesting a role for lipid asymmetry in ECV budding. Results: We show that loss of the conserved P4-ATPase TAT-5 causes the large-scale shedding of ECVs and disrupts cell adhesion and morphogenesis in Caenorhabditis elegans embryos. TAT-5 localizes to the plasma membrane and its loss results in phosphatidylethanolamine exposure on cell surfaces. We show that RAB-11 and endosomal sorting complex required for transport (ESCRT) proteins, which regulate the topologically analogous process of viral budding, are enriched at the plasma membrane in tat-5 embryos, and are required for ECV production. Conclusions: TAT-5 is the first protein identified to regulate ECV budding. TAT-5 provides a potential molecular link between loss of phosphatidylethanolamine asymmetry and the dynamic budding of vesicles from the plasma membrane, supporting the hypothesis that lipid asymmetry regulates budding. Our results also suggest that viral budding and ECV budding may share common molecular mechanisms.
Introduction
Extracellular vesicles (ECV) can act as messengers between cells. For example, ECVs can influence developmental fates by delivering morphogens such as Hedgehog [1] . ECVs released by platelets induce coagulation and can activate an immune response [2, 3] . Tumor cells release ECVs that promote metastasis, and infectious viral particles co-opt ECV biogenesis machinery to spread. ECVs form through two major routes. One pathway is via the direct budding of plasma membrane to form ECVs known as microparticles, microvesicles, or ectosomes. Alternatively, ECVs called exosomes form when multivesicular bodies fuse with the plasma membrane, releasing their intralumenal vesicles outside of the cell. Whereas the mechanisms responsible for exosome production are better understood, the molecular mechanisms that lead to ectosome budding remain a mystery.
Because the outer surfaces of ectosomes expose atypically high levels of the aminophospholipids phosphatidylserine (PS) and phosphatidylethanolamine (PE), it has been proposed that lipid externalization could facilitate ectosome formation on the plasma membrane [4] . PS and PE are normally asymmetrically enriched in the inner leaflet of the membrane bilayer. These lipids have conical shapes that can bend membranes, and PS is an anionic lipid that contributes to the negative charge of the membrane [5] . Interestingly, activated platelets from Scott syndrome patients cannot externalize PS or PE and fail to release ECVs to induce coagulation [6] , supporting a potential link between loss of lipid asymmetry and ECV budding.
Lipid asymmetry is mediated by transmembrane flippases from the P4 family of ATPases, which internalize phospholipids by translocating them from the outer to the inner leaflet of the bilayer [7] . PS translocase activity was definitively proven for yeast Drs2p and human ATP8B2 [8, 9] . Mutations in each of the five S. cerevisiae P4-ATPases cause defects in vesicle biogenesis or transport [10] . Humans have 14 P4-ATPases, many of which are uncharacterized, but mutations in the PS flippase ATP8B1 cause intrahepatic cholestasis [7] . Hepatocytes progressively lose microvilli and ATP8B1 is implicated in maintaining membrane integrity [11] . Despite the potential connection between disrupted lipid asymmetry and ectosome production, no P4-ATPase has been shown to inhibit ectosome formation.
A link between lipid flipping and cellular phenotype has also been established in Caenorhabditis elegans, which contains six P4-ATPases (TAT-1 to TAT-6) [12] . The Drs2p homolog TAT-1 is required to prevent PS exposure and thereby regulates cell corpse engulfment [13, 14] . TAT-1 has also been implicated in lysosome biogenesis and endocytosis [15, 16] . TAT-2, TAT-3, and TAT-4 regulate sterol or branched chain fatty acid metabolism through mechanisms that have not yet been established [12, 17] . The Neo1p homolog TAT-5 is the sole essential P4-ATPase in C. elegans, but its role has not yet been determined.
Here, we identify TAT-5 for its requirement during morphogenesis in the C. elegans embryo. We show that TAT-5 localizes to the plasma membrane and is needed to prevent PE exposure. Loss of TAT-5 causes the large-scale budding of vesicles from the plasma membrane, compromising cell adhesion and leading to defects in cell shape. We show that the robust production of ECVs depends on RAB-11, a GTPase associated with recycling endosomes; and the endosomal sorting complex required for transport (ESCRT) proteins, which form multivesicular bodies. These proteins are enriched at the plasma membrane in tat-5 embryos and are known to regulate the budding of viruses from the plasma membrane [18, 19] . Our findings identify the first P4-ATPase that inhibits ECV budding, providing a link between PE asymmetry, regulators of viral budding, and ECV biogenesis.
Results

TAT-5 Is Needed for Robust Cell Adhesion and Dynamic Changes in Cell Shape
We identified TAT-5 in an RNA interference (RNAi) screen for essential genes important for morphogenesis in C. elegans embryos. Morphogenesis begins at gastrulation when the endodermal precursors flatten their apical surfaces and ingress into the center of the embryo ( Figure 1A ; see also Movie S1 available online) [20] . In tat-5(RNAi) embryos, the endodermal precursors remained rounded and failed to ingress ( Figure 1B ; Movie S1), even though they expressed endoderm-specific markers ( Figures 1C and 1D ) and showed characteristic cell cycle lengths. Therefore, ingression defects in tat-5(RNAi) embryos did not result from a defect in specification.
To confirm the specificity of tat-5 RNAi, we examined embryos in two uncharacterized deletions that remove portions of tat-5 (tm1741 and tm1772). TAT-5 contains an ATPase domain and ten transmembrane domains. Both deletions remove part of the ATPase domain and the third transmembrane domain and are predicted to create frameshifts that eliminate the remainder of the protein. Over 95% of tat-5 mutants were sterile (n = 179), but rare worms produced a few embryos with rounded cells that invariably died ( Figure S1B ) like tat-5(RNAi) embryos. Because tat-5(RNAi) and tat-5 mutant embryos have indistinguishable phenotypes, hereafter we use RNAi for phenotypic analysis of tat-5. Mutations or RNAi that target the other P4-ATPases did not cause lethality [12] or disrupt cell shape (data not shown). Thus, TAT-5, but not other P4-ATPases, is required for the cell shape changes and movements that occur during gastrulation.
Because similar defects are observed in embryos lacking the adhesion proteins HMR-1/E-cadherin and SAX-7/L1CAM [21] , we investigated whether tat-5 embryos have defects in cell adhesion. In wild-type 4-cell embryos, the ventral cell EMS extends an adhesive protrusion along the anterior cell ABa ( Figure 1E ; Movie S1). By contrast, EMS remained rounded and did not protrude in tat-5 embryos ( Figure 1F ). When we removed the confining eggshell, it was evident that all tat-5 cells were rounded in comparison to wild-type ( Figures  1G and 1H ; Movie S2). There was a significant increase in cell circularity in tat-5 embryos, and the length of cell-cell contacts was reduced (see Supplemental Experimental Procedures). Cells in tat-5 embryos were also easily dissociated during devitellinization (14/30 embryos), in contrast to wild-type (1/23 embryos). However, loss of TAT-5 does not disrupt morphogenesis by preventing the localization of HMR-1 and SAX-7 to cell contacts ( Figures S1C-S1F ). Thus, cell adhesion is weakened in tat-5 mutant embryos through a novel mechanism, and poor adhesion may explain the observed defects in cell shape and morphogenesis.
Extracellular Tubulovesicular Structures Accumulate in tat-5 Embryos
We next asked whether tat-5 embryos had defects in the organization of the plasma membrane that could disrupt cell adhesion. Using a reporter (PH PLC1v1 ::mCherry) that localizes to the plasma membrane, we observed patches of increased labeling in tat-5 embryos ( Figure 2B ) compared to wild-type embryos (Figure 2A ). Similarly increased membrane labeling was observed in embryos from tat-5 deletion mutants ( Figure S2D ) and also with transmembrane proteins such as HMR-1 and SAX-7 ( Figures S1D and S1F ). This phenotype suggests that tat-5 embryos accumulate extra membrane on the surfaces of cells, which could disrupt cell contacts.
To reveal the nature of the extra membrane in tat-5 embryos, we performed an ultrastructural analysis using transmission electron microscopy (TEM). Cell-cell contacts in control embryos were evident as a pair of 5 nm thick plasma membranes that were rarely separated ( Figure 2C ). In tat-5 embryos, the plasma membranes were separated by a gap up to 300 nm in thickness, which contained numerous extracellular vesicles or tubules ( Figure 2D ). Hereafter, we refer to these heterogeneous structures as ECVs. ECVs were also present on the surface of 1-cell tat-5 embryos ( Figure 2F ) but were rare in wild-type embryos ( Figure 2E) . We conclude that the extra labeling with PH PLC1v1 ::mCherry in tat-5 embryos corresponds to the ECVs we observe by TEM. We hypothesize that these membrane structures interrupt the contacts between cells and are responsible for the weakened cell adhesion we observe in tat-5 embryos.
To demonstrate that the ECVs were vesicles not villi, we used electron tomography to generate three-dimensional reconstructions of the cell surface. In tat-5 embryos, we found spherical vesicles, cup-shaped vesicles, and large tubulovesicular structures ( Figure 3A ; Movie S3). Most ECVs within a 200 nm section did not connect to the plasma membrane and therefore are unlikely to be villi or intercellular bridges. To confirm that most ECVs were outside the cell, we asked whether proteins on the ECV membrane or their contents were protected from degradation. When proteins tagged with the PIE-1 ZF1 domain are expressed in the early embryo, they are rapidly degraded in somatic cells [22] . We tagged the integral plasma membrane protein SYX-4/syntaxin with the ZF1 domain and GFP to assess its ability to be degraded in tat-5 embryos. In wild-type embryos, GFP::ZF1::SYX-4 initially localized to the plasma membrane but was rapidly endocytosed and degraded as somatic cells formed ( Figure 3C ). In tat-5 embryos, GFP::ZF1::SYX-4 was internalized and degraded over much of the surface of somatic cells but remained within thickened patches that costained with SAX-7 ( Figure 3D ). We observed a similar pattern of protection when ZF1-tagging the cortical proteins PAR-3 and PAR-6 in tat-5 embryos (data not shown). These findings suggest that ECVs protect ZF1-tagged proteins from degradation because they are not connected to the cell, supporting the tomography data.
Extracellular Vesicles in tat-5 Embryos Form by Plasma Membrane Budding
We next analyzed whether the ECVs in tat-5 embryos were exosomes or ectosomes. Exosomes are 40-100 nm diameter vesicles derived from the intralumenal vesicles of multivesicular bodies (MVBs) [3] . To determine whether ECVs in tat-5 embryos are exosomes, we compared the diameter of ECVs and intralumenal MVB vesicles. The ECVs were significantly larger than intralumenal vesicles in tat-5 embryos (p < 10 240 ), with little overlap ( Figure 3B ). Rare ECVs in wild-type embryos were also larger than wild-type intralumenal vesicles (ECV: 218 6 62 nm, n = 20 from five embryos; MVB: 57 6 16 nm, n = 106 from three embryos, p < 10 29 ). Additionally, we never observed MVBs fusing with the plasma membrane in tomograms from tat-5 embryos (over 40 mm of cell contact examined). The simple shapes of exosomes [3] are also inconsistent with the complicated tubulovesicular structures we observed in tat-5 ECVs ( Figure 3A) . Finally, tat-5 ECVs did not label with LMP-1/LAMP1 ( Figure S3 ), a marker of exosomes in other systems [2] . Thus, we can find no evidence that the ECVs derive from MVBs.
We next tested whether ECVs formed through the direct budding of the plasma membrane as ectosomes. Ectosomes are larger than exosomes (100-1,000 nm), consistent with the observed size range of ECVs, and tend to have more irregular shapes [3] . We also observed 36 vesicles in tat-5 embryos (in 40 mm of cell contact) that were connected to the plasma membrane ( Figure 3A 0 ). We never observed a vesicle attached to the plasma membrane in tomograms from wild-type embryos (in 24 mm examined) and cannot conclude whether the ECVs from wild-type and tat-5 embryos are equivalent.
The labeling of ECVs with plasma membrane markers such as PH PLC1v1 ::mCherry, GFP::ZF1::SYX-4, HMR-1, and SAX-7 is also consistent with a cell surface origin (Figures 2B and  3D ; Figures S1D and S1F) . Together, our observations suggest that most or all ECVs in tat-5 embryos are ectosomes that form by plasma membrane budding.
ECVs Are Formed throughout Embryogenesis
To determine whether ECVs are made continuously, we used a reporter that would mark new but not preexisting ECVs. The med-1::GFP::CAAX transgene is expressed in a subset of cells after the 7-cell stage and labels the cytoplasmic face of the membrane. In control embryos, GFP::CAAX labeled the plasma membrane and thin filopodia-like protrusions ( Figure 3E ). In tat-5 embryos, GFP::CAAX accumulated in large patches on the surface of cells ( Figure 3F ). These observations suggest that early embryonic cells produce ECVs continuously.
TAT-5 Localizes to the Plasma Membrane
To determine whether TAT-5 functions where ectosomes are produced, we expressed a GFP-tagged transgene. GFP::TAT-5 is functional and can rescue the sterility of tat-5 deletion alleles (>60% fertile, n = 61 adults, 2 transgenes). In early embryos, GFP::TAT-5 was found primarily at the plasma membrane but also labeled some cytoplasmic vesicles ( Figure 4A ). GFP::TAT-5 also rescued the extra membrane observed in tat-5 embryos ( Figure 4C ). The localization of GFP::TAT-5 to the plasma membrane is consistent with TAT-5 acting on the cell surface.
The ATPase activity of P4-ATPases is required for their lipid flippase action [8] . To determine whether ATPase activity is required for TAT-5 to prevent plasma membrane budding, we mutated two sites essential for activity of P-type ATPases: the aspartyl phosphorylation site (D439) or the motif required for dephosphorylation of D439 [23] . GFP::TAT-5(D439E) did not localize to the plasma membrane ( Figures  S4A-S4D ), whereas GFP::TAT-5(E246Q) localized to the plasma membrane ( Figure 4B ) but failed to rescue the sterility and maternal-effect embryonic lethality of tat-5 mutants (n = 120 adults, 2 transgenes). GFP::TAT-5(E246Q) localized to membrane thickenings in embryos from tat-5 mutants (Figure 4D) , demonstrating that TAT-5 ATPase activity is required to prevent ECV formation.
TAT-5 Is Required to Prevent Cell Surface Exposure of PE
Ectosomes have been associated with high levels of externalized PS and PE [4] . As a P4-ATPase, TAT-5 is predicted to regulate the bilayer asymmetry of one or more aminophospholipids. To establish whether PS asymmetry was altered in tat-5 embryos, we stained the surface of unpermeabilized embryos with Annexin V, a protein that specifically recognizes PS [24] . In control embryos, Annexin V labeled the plasma membrane and endocytosed puncta weakly ( Figures 4E and 4H) . In tat-1 mutants, embryonic cells stained brightly with Annexin V (Figures 4F and 4H) , consistent with reports that PS was exposed on the surface of tat-1 germ cells [13] . In tat-5 embryos, we observed weak labeling similar to control embryos, even at regions where ectosomes accumulate ( Figures 4G and 4H) . We conclude that TAT-5 is not required to prevent cell surface exposure of PS (in contrast to TAT-1), and we find no evidence that ectosomes in tat-5 mutants externalized PS.
To analyze PE asymmetry, we used duramycin, which specifically binds PE [25] . In cultured cells, PE is externalized during cytokinetic furrow ingression [26] . Consistent with these observations, duramycin stained a subset of cell contacts in unpermeabilized wild-type embryos ( Figure 4I) , and staining was similar in tat-1 embryos ( Figure 4J ). However, in tat-5 embryos, duramycin staining was more uniform around the plasma membrane and brightly labeled membrane thickenings ( Figure 4K ). The intensity of membrane staining, both at regions with and without patches of ectosomes, was significantly higher in tat-5 embryos than in control embryos ( Figure 4L , p < 0.01). Increased surface PE was not due to a generally higher level of PE in tat-5 mutants, because levels of PE and other phospholipids were equivalent in wild-type and tat-5 ( Figures S4E-S4F ). These findings indicate that PE is inappropriately externalized on tat-5 embryonic cells.
Clathrin, RAB-11, and the ESCRT Complex Are Enriched at the Plasma Membrane in tat-5 Embryos
Given the unusual vesicles and mislocalized lipids in tat-5 embryos, we examined whether endocytosis and secretion were disrupted. We found no evidence for a defect in secretion using transgenes expressing secreted proteins ( Figures S5A-S5D) , and markers for clathrin-dependent endocytosis were normal in tat-5 ( Figures S5C-S5F ). We also found no defect in the localization of early endosomal, late endosomal, Golgi, or endoplasmic reticulum markers in tat-5 embryos ( Figures  S5G-S5N ), although lysosomes appeared enlarged ( Figures  S3A and S3B; Figures S5O and S5P) . Thus, loss of TAT-5 does not grossly disrupt membrane trafficking.
TAT-5 ortholog Neo1p has been linked to clathrin recruitment in yeast [27] , so we examined clathrin localization using a tagged heavy-chain subunit (CHC-1) [28] . In control embryos, GFP::CHC-1 was rapidly lost from the plasma membrane after fertilization and was mostly cytoplasmic by the 4-cell stage ( Figure 5A ). In 4-cell tat-5 embryos, GFP::CHC-1 was still enriched at the plasma membrane ( Figure 5B ). However, given that clathrin-mediated endocytosis was not defective in tat-5 embryos (Figures S5E and S5F) , the enrichment of clathrin at the plasma membrane suggests that clathrin recruitment or dissociation is aberrant in tat-5 embryos. We found a similar plasma membrane accumulation of proteins linked to viral shedding, which is provocative because viral particles can also form by plasma membrane budding. The small GTPase Rab11 is a regulator of recycling endosomes that is required for viral budding [18] . In control embryos, GFP::RAB-11 had a punctate distribution in the cytoplasm and on the cortex ( Figure 5C ). In tat-5 embryos, GFP::RAB-11 became continuous along the plasma membrane and had the same thickened appearance as other membrane markers ( Figure 5D ). The recycling endosome protein RME-1 showed a similar distribution (data not shown). Thus, recycling endosome markers are over-recruited to the plasma membrane or trapped in ECVs.
The ESCRT complex, which forms the intralumenal vesicles of MVBs, is also required for viral shedding [19] . Because ESCRT proteins do not stably associate with membranes unless the ESCRT recycling protein VPS-4 is inhibited [29] , we examined the localization of early and late ESCRT proteins in vps-4(RNAi) embryos. Proteins from the ESCRT-I (MVB-12) and ESCRT-III (VPS-32) complexes stably labeled MVBs as well as a small number of puncta on the plasma membrane of vps-4 embryos (Figures 5E and 5G) . In embryos from tat-5 + vps-4 double-stranded RNA (dsRNA) injections, we observed twice as many ESCRT-III puncta on the plasma membrane, and ESCRT-I proteins were similarly enriched ( Figures 5F and 5H) . ESCRT-III proteins do not label the plasma membrane in tat-5 embryos when VPS-4 is present, suggesting that ESCRT-III is not trapped within ectosomes (data not shown). These findings demonstrate that the ESCRT complex is recruited to the plasma membrane in tat-5 embryos.
RAB-11 and the ESCRT Complex Are Required for Ectosome Formation
Although externalized PE is predicted to promote outward curvature of the plasma membrane, PE exposure is unlikely to form complete vesicles without the assistance of proteins [5] . Given that viral budding regulators RAB-11 and the ESCRT complex were enriched at the plasma membrane in tat-5 embryos, we asked whether reducing their levels could suppress the thickened membrane phenotype (Figures 6A  and 6B ; Table S1 ). In embryos from tat-5 dsRNA injected adults, we found that 82% had severe membrane thickening ( Figure 6D ) compared to wild-type ( Figure 6C ). However, when we coinjected rab-11 and tat-5 dsRNA, embryos more closely resembled rab-11 single injections with only 11% of embryos showing the severe thickening typical of tat-5 (Figure 6E) . We verified that our double injections effectively targeted tat-5 by injecting the GFP::TAT-5 strain ( Figure S6 ). In addition, RNAi targeting clathrin adaptors AP1 at the Golgi (aps-1) or AP2 at the plasma membrane (aps-2) did not suppress tat-5 membrane thickening ( Figure 6A ), demonstrating that clathrin is unlikely to have a role in budding ectosomes and that suppression by RAB-11 is specific. These findings suggest that ectosomes arise from a RAB-11-dependent membrane pool or through a RAB-11-dependent process (see Discussion). Table S1 for n values.
Next, we examined a role for the ESCRT complex in ectosome formation. The ESCRT complex is broken into four subcomplexes: ESCRT-0 clusters cargo and recruits ESCRT-I, ESCRT-I and ESCRT-II form membrane buds, and ESCRT-III causes vesicle scission and release [19] . We found that dsRNA targeting ESCRT-0 or ESCRT-I complex members were able to partially suppress tat-5 membrane thickening ( Figure 6B ; Table S1 ). For example, only 33% of embryos from tat-5 + hgrs-1 (ESCRT-0) injections and 40% of embryos from tat-5 + vps-28 (ESCRT-I) injections showed severe membrane thickening (Figures 6F and 6G) . Targeting ESCRT-II, ESCRT-III (Figure 6H ), or associated factors VPS-4 and ALX-1 did not significantly suppress membrane thickenings, although these proteins could be involved in ectosome release rather than bud formation (see Discussion). Thus, these suppression and localization data suggest that ESCRT complex proteins are recruited to the plasma membrane in tat-5 embryos and are required to bud vesicles out of the cell.
Discussion
Impact of Cell Surface Organization on Morphogenesis
The lethality of tat-5 embryos highlights the importance of proper surface membrane structure for cell shape changes and morphogenesis. We propose that the accumulation of intercellular ectosomes in tat-5 embryos compromises morphogenesis by disrupting adhesion. For example, anterior spreading of the EMS cell and endodermal cell ingression do not occur in tat-5 embryos, and both of these events involve the formation of adhesive cellular protrusions [30, 31] . Although similar morphogenetic defects can arise from improper cell specification, specification occurs normally in tat-5 early embryos.
Plasma Membrane Aminophospholipids and Ectosome Formation PS and PE are externalized on ectosomes, and it was proposed that their externalization induces ectosome formation [4] . Our system allows us to test the potential contributions of PS and PE separately because of the specific effects tat-1 and tat-5 mutants have on lipid localization. PS asymmetry was not disrupted on the plasma membrane or on ectosomes in tat-5 embryos. Additionally, despite the dramatic externalization of PS in tat-1 mutants, they do not accumulate excess surface membrane (our unpublished data). Therefore, although PS externalization has important signaling roles [32] , PS externalization is neither necessary nor sufficient for ectosome formation. Although TAT-5 could regulate additional lipids, the physical characteristics of PE (described below) support the hypothesis that the loss of PE asymmetry induces ectosome budding.
A Model for Ectosome Formation
TAT-5 is the first protein shown to repress both PE externalization and ectosome production and provides a potential link between these events. PE externalization occurs slowly unless induced by lipid scramblases, which abolish lipid asymmetry [32] . We predict that TAT-5 opposes the action of a scramblase to maintain PE asymmetry and inhibit ectosome formation ( Figure 7) . Patients with Scott syndrome, whose platelets fail to release ECVs [6] , were found to carry mutations in a potential scramblase [33] , further correlating loss of lipid asymmetry and ECV production. This raises the possibility that human P4-ATPases (such as TAT-5 homologs ATP9A/B) may regulate ECV formation and coagulation in platelets.
PE is an abundant, zwitterionic lipid with a small head group and conical shape [5] , and we can envision both indirect and direct roles for PE in budding ( Figures 7A and 7B) . First, PE externalization could alter the local charge of the plasma membrane by increasing the density of sparser lipids in the inner leaflet, such as anionic PS and phosphatidylinositols (PI), resulting in the formation of anionic microdomains. Anionic microdomains could recruit or stabilize membranesculpting proteins that promote ectosome formation (Figure 7A ). For example, mammalian Hrs (ESCRT-0) binds anionic lipids [19] . We observed that HGRS-1/Hrs was required for efficient ectosome production, and ESCRT proteins were enriched at the cell surface in tat-5 embryos. Clathrin, which was similarly enriched at the cell surface in tat-5 embryos, can also bind to anionic lipids or be recruited by Hrs [19, 34] .
A second potential mechanism by which externalized PE could lead to ectosome budding is through the formation of PE-rich microdomains within the outer leaflet. Because of PE's . PE externalization by an unknown scramblase could lead to the recruitment or stabilization of the ESCRT complex to the plasma membrane, where the ESCRT complex buds out ectosomes. RAB-11 could deliver proteins needed for budding to the plasma membrane or could have a more direct role in the budding process. (A) Externalized PE results in microdomains of increased negative charge at the cytoplasmic face (from relatively increased phosphatidylserine and phosphatidylinositols density). (B) Externalized PE induces domains of negative membrane curvature that could act as hinge regions. These models are not exclusive.
conical shape [5] , microdomains of PE could act as hinges to induce negative membrane curvature ( Figure 7B ). Indeed, PE-rich microdomains that contain membrane-localized ESCRT proteins have been implicated in HIV budding [35] .
RAB-11 and the ESCRT Complex in Ectosome Production
Our suppression studies indicate that RAB-11 has an important role in ectosome production. Both recycling endosome markers we examined showed plasma membrane accumulation in tat-5 embryos, raising the possibility that RAB-11-dependent recycling of lipids or proteins to the plasma membrane may be necessary for ectosome production. One possibility is that RAB-11 delivers the ESCRT complex to the plasma membrane. Alternatively, RAB-11 may have a direct role in promoting ectosome budding, as has been suggested for viral budding [18] . RAB-11 also promotes exosome production [3] , suggesting that ectosomes and exosomes may be regulated by common pathways despite their distinct subcellular origins.
The ESCRT proteins are well known for their role in forming viral particles, but only recently have they been implicated in ectosome budding [36] . HIV-1 budding requires ESCRT-I, ESCRT-III, ALIX, and VPS4. The viral Gag protein recruits ESCRT-I in place of ESCRT-0 [19] . We found that inhibiting ESCRT-0 or ESCRT-I suppressed ECV formation in tat-5 embryos, but surprisingly, inhibiting ESCRT-III, ALX-1, or VPS-4 did not. However, we believe that ESCRT-III is likely to take part based on its recruitment to the plasma membrane in tat-5 embryos. Given that the ESCRT-III complex is required for scission, lack of suppression might reflect our inability to distinguish stalled buds from released ectosomes by light microscopy. By contrast, reducing ESCRT-0/I should prevent bud formation early, and therefore reduce buildup of excess membrane. Notably, inhibiting ESCRT-0/I proteins only partially suppressed ectosome production in tat-5 embryos. Although this may reflect partial knockdown, another possibility is that ESCRT proteins regulate the production of a subset of ectosomes. Indeed, a VPS4-independent mechanism for viral budding has recently been identified, and this budding is dependent on a Rab11-binding protein [37] .
The Cellular Role of TAT-5 Homologs
The role of the TAT-5 subfamily of P4-ATPases has not been examined in other multicellular organisms, but studies in yeast suggest that some aspects of TAT-5 function may be conserved. For example, although yeast Neo1p localizes predominantly to endomembranes and Golgi, neo1 mutants have ultrastructural phenotypes such as the formation of unusual tubular and multivesicular structures [38, 39] . Because the intralumenal vesicles of MVBs share the same topology as ectosomes, this phenotype could reflect an analogous role for Neo1p in inhibiting the outward budding of endosomal membranes. It will be important to determine whether yeast and mammalian TAT-5 homologs have a similar role in maintaining PE asymmetry and to test whether they can influence the release of ectosomes or the budding of viral particles from cells.
Experimental Procedures
Worms were grown at 25 C unless stated otherwise. Time-lapse, differential interference contrast (DIC), and fluorescent images were acquired and processed as described [40, 41] . Extended Experimental Procedures are available in the Supplemental Information.
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